Stevanato group announces agreement with barda for the expansion of vial production to create industrial base capabilities for national defense

Piombino dese, italy--(business wire)--stevanato group (nyse: stvn), a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced today that its subsidiary, ompi of america inc., entered into an agreement to support the biomedical advanced research and development authority (“barda”, part of the office of the assistant secretary for preparedness and response at the u.s. department of health and human s
STVN Ratings Summary
STVN Quant Ranking